HL7 BE Laboratory WG Implementation Guide
1.0.0 - STU
HL7 BE Laboratory WG Implementation Guide
1.0.0 - STU
This page is part of the HL7 Belgium FHIR Implementation Guide - Lab related profiles (v1.0.0: Trial Use) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions 
{
"resourceType" : "Bundle",
"id" : "antibiogramAsBundleNN",
"identifier" : {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:uuid:0c3151bd-1cbf-4d99-b04d-cd9187a4c6e0"
},
"type" : "collection",
"entry" : [
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d34",
"resource" : {
"resourceType" : "DiagnosticReport",
"id" : "diagnosticreport50",
"meta" : {
"versionId" : "1",
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-laboratory-report"
]
},
"language" : "en",
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier" : [
{
"system" : "https://www.ehealth.fgov.be/lab-report/diagnostic-report-id",
"value" : "11530231003.2015110413180000000"
}
],
"basedOn" : [
{
"reference" : "ServiceRequest/servicerequest50"
}
],
"status" : "final",
"category" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
"code" : "LAB",
"display" : "Laboratory"
},
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
"code" : "MB",
"display" : "Microbiology"
}
]
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "18769-0",
"display" : "Microbial susceptibility tests Set"
}
],
"text" : "Microbial susceptibility tests"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-03T13:18:00+01:00",
"issued" : "2015-11-04T13:18:00+01:00",
"performer" : [
{
"reference" : "Organization/organization10"
}
],
"resultsInterpreter" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"specimen" : [
{
"reference" : "Specimen/specimen50"
}
],
"result" : [
{
"reference" : "Observation/org51"
},
{
"reference" : "Observation/org52"
},
{
"reference" : "Observation/dr50-mrsa"
},
{
"reference" : "Observation/dr50-mrgn"
}
],
"conclusion" : "This is our conclusion"
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d36",
"resource" : {
"resourceType" : "Specimen",
"id" : "specimen50",
"meta" : {
"versionId" : "1",
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-specimen-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier" : [
{
"system" : "https://www.GTL-LABO.be/",
"value" : "1"
}
],
"status" : "available",
"type" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "258529004",
"display" : "Throat swab"
}
],
"text" : "A string can be added to nuance or explain."
},
"receivedTime" : "2015-11-04",
"note" : [
{
"text" : "Some extra relevant information concerning the specimen"
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d37",
"resource" : {
"resourceType" : "Observation",
"id" : "org51",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "73960-7",
"display" : "Bacteria identified in Mouth by Culture"
}
]
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "243301005",
"display" : "Morganella morganii"
}
]
},
"specimen" : {
"reference" : "Specimen/specimen50"
},
"hasMember" : [
{
"reference" : "Observation/org51-ampicilin"
},
{
"reference" : "Observation/org51-trimethoprim-sulfamethoxazole"
},
{
"reference" : "Observation/org51-nitrofurantoin"
},
{
"reference" : "Observation/org51-cefuroxime"
},
{
"reference" : "Observation/org51-gentamicin"
},
{
"reference" : "Observation/org51-colistin"
},
{
"reference" : "Observation/org51-temocillin"
},
{
"reference" : "Observation/org51-fosfomycin"
},
{
"reference" : "Observation/org51-levofloxacin"
},
{
"reference" : "Observation/org51-ofloxacin"
},
{
"reference" : "Observation/org51-amoxicillin-clavulanate"
},
{
"reference" : "Observation/org51-amikacin"
},
{
"reference" : "Observation/org51-piperacillin-tazobactam"
},
{
"reference" : "Observation/org51-ceftriaxone"
},
{
"reference" : "Observation/org51-cefotaxime"
},
{
"reference" : "Observation/org51-ceftazidime"
},
{
"reference" : "Observation/org51-meropenem"
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d38",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-ampicilin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "29-9",
"display" : "Ampicillin [Susceptibility] by Disk diffusion (KB)"
}
],
"text" : "Ampicillin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "R",
"display" : "Resistant"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d39",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-trimethoprim-sulfamethoxazole",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "516-5",
"display" : "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Trimethoprim+Sulfamethoxazole"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d40",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-nitrofurantoin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "363-2",
"display" : "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Nitrofurantoin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "R",
"display" : "Resistant"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d41",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-cefuroxime",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "51774-8",
"display" : "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Cefuroxime"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "R",
"display" : "Resistant"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d42",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-gentamicin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "267-5",
"display" : "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Gentamicin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d43",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-colistin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "205-5",
"display" : "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Colistin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "R",
"display" : "Resistant"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d44",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-temocillin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "492-9",
"display" : "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Temocillin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d45",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-fosfomycin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "25653-7",
"display" : "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Fosfomycin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d46",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-levofloxacin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "20396-8",
"display" : "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Levofloxacin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d47",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-ofloxacin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "375-6",
"display" : "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Ofloxacin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d48",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-amoxicillin-clavulanate",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "20-8",
"display" : "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Amoxicillin+Clavulanate"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "R",
"display" : "Resistant"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d49",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-amikacin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "12-5",
"display" : "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Amikacin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d50",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-piperacillin-tazobactam",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "412-7",
"display" : "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Piperacillin+Tazobactam"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d51",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-ceftriaxone",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "141-2",
"display" : "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Ceftriaxone"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d52",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-cefotaxime",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "108-1",
"display" : "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Cefotaxime"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d53",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-ceftazidime",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "133-9",
"display" : "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Ceftazidime"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d54",
"resource" : {
"resourceType" : "Observation",
"id" : "org51-meropenem",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "6652-2",
"display" : "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Meropenem"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d55",
"resource" : {
"resourceType" : "Observation",
"id" : "org52",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "73960-7",
"display" : "Bacteria identified in Mouth by Culture"
}
]
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "112283007",
"display" : "Escherichia coli"
}
]
},
"specimen" : {
"reference" : "Specimen/specimen50"
},
"hasMember" : [
{
"reference" : "Observation/org52-ampicilin"
},
{
"reference" : "Observation/org52-trimethoprim-sulfamethoxazole"
},
{
"reference" : "Observation/org52-nitrofurantoin"
},
{
"reference" : "Observation/org52-cefuroxime"
},
{
"reference" : "Observation/org52-gentamicin"
},
{
"reference" : "Observation/org52-colistin"
},
{
"reference" : "Observation/org52-temocillin"
},
{
"reference" : "Observation/org52-fosfomycin"
},
{
"reference" : "Observation/org52-levofloxacin"
},
{
"reference" : "Observation/org52-ofloxacin"
},
{
"reference" : "Observation/org52-amoxicillin-clavulanate"
},
{
"reference" : "Observation/org52-amikacin"
},
{
"reference" : "Observation/org52-piperacillin-tazobactam"
},
{
"reference" : "Observation/org52-ceftriaxone"
},
{
"reference" : "Observation/org52-cefotaxime"
},
{
"reference" : "Observation/org52-ceftazidime"
},
{
"reference" : "Observation/org52-meropenem"
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d56",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-ampicilin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "29-9",
"display" : "Ampicillin [Susceptibility] by Disk diffusion (KB)"
}
]
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d57",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-trimethoprim-sulfamethoxazole",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "516-5",
"display" : "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Trimethoprim+Sulfamethoxazole"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d58",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-nitrofurantoin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "363-2",
"display" : "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Nitrofurantoin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d59",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-cefuroxime",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "51774-8",
"display" : "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Cefuroxime"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d60",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-gentamicin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "267-5",
"display" : "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Gentamicin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d61",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-colistin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "205-5",
"display" : "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Colistin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d62",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-temocillin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "492-9",
"display" : "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Temocillin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d63",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-fosfomycin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "25653-7",
"display" : "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Fosfomycin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d64",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-levofloxacin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "20396-8",
"display" : "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Levofloxacin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d65",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-ofloxacin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "375-6",
"display" : "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Ofloxacin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d66",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-amoxicillin-clavulanate",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "20-8",
"display" : "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Amoxicillin+Clavulanate"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d67",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-amikacin",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "12-5",
"display" : "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Amikacin"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d68",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-piperacillin-tazobactam",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "412-7",
"display" : "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Piperacillin+Tazobactam"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d69",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-ceftriaxone",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "141-2",
"display" : "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Ceftriaxone"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d70",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-cefotaxime",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "108-1",
"display" : "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Cefotaxime"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d71",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-ceftazidime",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "133-9",
"display" : "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Ceftazidime"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d72",
"resource" : {
"resourceType" : "Observation",
"id" : "org52-meropenem",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "6652-2",
"display" : "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text" : "Meropenem"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"interpretation" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code" : "S",
"display" : "Susceptible"
}
]
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d80",
"resource" : {
"resourceType" : "Observation",
"id" : "dr50-mrsa",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "35492-8",
"display" : "Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Unspecified specimen by NAA with probe detection"
}
],
"text" : "MRSA"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"valueString" : "negative"
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d81",
"resource" : {
"resourceType" : "Observation",
"id" : "dr50-mrgn",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "78702-8",
"display" : "Multiple drug resistant gram negative organism [Identifier] in Unspecified specimen by Culture"
}
],
"text" : "MRGN"
},
"subject" : {
"reference" : "Patient/patient1"
},
"effectiveDateTime" : "2015-11-04T09:16:00-05:00",
"issued" : "2015-11-04T09:16:00-05:00",
"performer" : [
{
"reference" : "Practitioner/practitioner11"
}
],
"valueString" : "negative"
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d72",
"resource" : {
"resourceType" : "Organization",
"id" : "organization10",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-organization"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier" : [
{
"use" : "official",
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "MD",
"display" : "Medical License number"
}
]
},
"system" : "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi",
"value" : "81165343998"
}
],
"active" : true,
"type" : [
{
"coding" : [
{
"system" : "https://www.ehealth.fgov.be/standards/fhir/core/CodeSystem/cd-hcparty",
"code" : "orglaboratory"
}
]
}
],
"name" : "GTL - General Testing Laboratory",
"telecom" : [
{
"system" : "phone",
"value" : "322675199",
"use" : "work"
}
],
"address" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/language",
"valueCode" : "nl"
}
],
"use" : "work",
"type" : "both",
"text" : "Vulcansstraat 120, 1000 Brussel",
"line" : [
"Vulcansstraat 120"
],
"_line" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-streetName",
"valueString" : "Vulcansstraat"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-houseNumber",
"valueString" : "120"
}
]
}
],
"city" : "Brussel",
"postalCode" : "1000",
"country" : "BE"
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d73",
"resource" : {
"resourceType" : "Practitioner",
"id" : "practitioner11",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-practitioner"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi",
"value" : "554488997"
}
],
"name" : [
{
"use" : "official",
"family" : "Davoust",
"given" : [
"Nicolas"
]
}
],
"telecom" : [
{
"system" : "email",
"value" : "nicolas.davoust@gtl.be",
"use" : "work"
},
{
"system" : "phone",
"value" : "022675198",
"use" : "work"
},
{
"system" : "fax",
"value" : "022675209",
"use" : "work"
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d74",
"resource" : {
"resourceType" : "Patient",
"id" : "patient1",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-patient"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/ssin",
"value" : "79121137740"
}
],
"active" : true,
"name" : [
{
"family" : "La Paradisio",
"given" : [
"Josephine",
"Nessa"
]
}
],
"telecom" : [
{
"system" : "email",
"value" : "nessa.laparadisio@belgium.be"
},
{
"system" : "phone",
"value" : "+322476792979",
"use" : "mobile"
},
{
"system" : "phone",
"value" : "+3226718655",
"use" : "home"
},
{
"system" : "phone",
"value" : "+322476799",
"use" : "work"
}
],
"gender" : "female",
"birthDate" : "1979-12-11",
"_birthDate" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/patient-birthTime",
"valueDateTime" : "1979-12-11T13:28:17-05:00"
}
]
},
"address" : [
{
"use" : "home",
"type" : "both",
"text" : "Sloordelle 42, 1160 Oudergem",
"line" : [
"Sloordelle 42"
],
"city" : "Oudergem",
"postalCode" : "1160",
"country" : "BE"
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d75",
"resource" : {
"resourceType" : "ServiceRequest",
"id" : "servicerequest50",
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier" : [
{
"system" : "https://www.GTL-LABO.be/orderingsystem",
"value" : "12334546"
}
],
"status" : "active",
"intent" : "order",
"category" : [
{
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "108252007",
"display" : "Laboratory procedure"
}
]
}
],
"subject" : {
"reference" : "Patient/patient1"
},
"authoredOn" : "2015-11-01T14:41:00+01:00",
"requester" : {
"reference" : "Practitioner/practitioner1"
},
"specimen" : [
{
"reference" : "Specimen/specimen50"
}
]
}
},
{
"fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d76",
"resource" : {
"resourceType" : "Practitioner",
"id" : "practitioner1",
"meta" : {
"profile" : [
"https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-practitioner"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi",
"value" : "18749704477"
}
],
"name" : [
{
"use" : "official",
"family" : "Pulaski",
"given" : [
"Katherine"
],
"suffix" : [
"MD"
]
}
],
"telecom" : [
{
"system" : "email",
"value" : "katherine.pulaski@enterprisehospital.be",
"use" : "work"
},
{
"system" : "phone",
"value" : "022675198",
"use" : "work"
},
{
"system" : "fax",
"value" : "022675209",
"use" : "work"
}
],
"address" : [
{
"use" : "home",
"text" : "Jupiterlaan 5, 1853 Grimbergen",
"line" : [
"Jupiterlaan 5"
],
"city" : "Grimbergen",
"postalCode" : "1853",
"country" : "BE"
}
]
}
}
]
}
IG © 2021+ eHealth Platform. Package hl7.fhir.be.lab#1.0.0 based on FHIR 4.0.1. Generated 2022-09-08
Links: Table of Contents |
QA Report
| Issues
